Literature DB >> 25241021

IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia.

Emily G Severance1, Kristin L Gressitt2, Armin Alaedini3, Cathrin Rohleder4, Frank Enning5, J Malte Bumb4, Juliane K Müller4, Emanuel Schwarz4, Robert H Yolken2, F Markus Leweke4.   

Abstract

Schizophrenia is a complex brain disorder that may be accompanied by idiopathic inflammation. Classic central nervous system (CNS) inflammatory disorders such as viral encephalitis or multiple sclerosis can be characterized by incongruent serum and cerebrospinal fluid (CSF) IgG due in part to localized intrathecal synthesis of antibodies. The dietary antigens, wheat gluten and bovine milk casein, can induce a humoral immune response in susceptible individuals with schizophrenia, but the correlation between the food-derived serological and intrathecal IgG response is not known. Here, we measured IgG to wheat gluten and bovine milk casein in matched serum and CSF samples from 105 individuals with first-episode schizophrenia (n=75 antipsychotic-naïve), and 61 controls. We found striking correlations in the levels of IgG response to dietary proteins between serum and CSF of schizophrenia patients, but not controls (schizophrenia, R(2)=0.34-0.55, p⩽0.0001; controls R(2)=0.05-0.06, p>0.33). A gauge of blood-CSF barrier permeability and CSF flow rate, the CSF-to-serum albumin ratio, was significantly elevated in cases compared to controls (p⩽0.001-0.003). Indicators of intrathecal IgG production, the CSF IgG index and the specific Antibody Index, were not significantly altered in schizophrenia compared to controls. Thus, the selective diffusion of bovine milk casein and wheat gluten antibodies between serum and CSF in schizophrenia may be the function of a low-level anatomical barrier dysfunction or altered CSF flow rate, which may be transient in nature.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arachnoid membrane; Autism; Bipolar disorder; Blood–brain barrier; Choroid plexus; Endothelial; Epithelial; Gastrointestinal; Psychoses

Mesh:

Substances:

Year:  2014        PMID: 25241021      PMCID: PMC4275312          DOI: 10.1016/j.bbi.2014.09.009

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  127 in total

1.  Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers.

Authors:  William Eaton; Preben Bo Mortensen; Esben Agerbo; Majella Byrne; Ole Mors; Henrik Ewald
Journal:  BMJ       Date:  2004-02-21

2.  Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I.

Authors:  Armin Alaedini; Haruka Okamoto; Chiara Briani; Kurt Wollenberg; Holly A Shill; Khalafalla O Bushara; Howard W Sander; Peter H R Green; Mark Hallett; Norman Latov
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

3.  Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Crystal Vaughan; Sunil Khushalani; Flora Leister; Shuojia Yang; Bogdana Krivogorsky; Armin Alaedini; Robert Yolken
Journal:  Biol Psychiatry       Date:  2010-05-14       Impact factor: 13.382

4.  A left temporal lobe arachnoid cyst in a patient with schizophrenia-like psychosis: a case report.

Authors:  Murat Kuloglu; Ali Caykoylu; Elif Yilmaz; Okan Ekinci
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-04-29       Impact factor: 5.067

5.  Elevated gliadin antibody levels in individuals with schizophrenia.

Authors:  Olaoluwa Okusaga; Robert H Yolken; Patricia Langenberg; Aamar Sleemi; Deanna L Kelly; Dipika Vaswani; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Farooq Mohyuddin; Maureen W Groer; Dan Rujescu; Teodor T Postolache
Journal:  World J Biol Psychiatry       Date:  2013-01-03       Impact factor: 4.132

6.  A study of circulating gliadin antibodies in schizophrenia among a Chinese population.

Authors:  Shun-Zi Jin; Ning Wu; Qi Xu; Xuan Zhang; Gui-Zhi Ju; Matthew H Law; Jun Wei
Journal:  Schizophr Bull       Date:  2010-09-30       Impact factor: 9.306

7.  Common variants on chromosome 6p22.1 are associated with schizophrenia.

Authors:  Jianxin Shi; Douglas F Levinson; Jubao Duan; Alan R Sanders; Yonglan Zheng; Itsik Pe'er; Frank Dudbridge; Peter A Holmans; Alice S Whittemore; Bryan J Mowry; Ann Olincy; Farooq Amin; C Robert Cloninger; Jeremy M Silverman; Nancy G Buccola; William F Byerley; Donald W Black; Raymond R Crowe; Jorge R Oksenberg; Daniel B Mirel; Kenneth S Kendler; Robert Freedman; Pablo V Gejman
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

8.  Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia.

Authors:  D G Kirch; R C Alexander; R L Suddath; N M Papadopoulos; C A Kaufmann; D G Daniel; R J Wyatt
Journal:  J Neural Transm Gen Sect       Date:  1992

Review 9.  Cerebrospinal fluid stasis and its clinical significance.

Authors:  James M Whedon; Donald Glassey
Journal:  Altern Ther Health Med       Date:  2009 May-Jun       Impact factor: 1.305

10.  Novel immune response to gluten in individuals with schizophrenia.

Authors:  Diana Samaroo; Faith Dickerson; Donald D Kasarda; Peter H R Green; Chiara Briani; Robert H Yolken; Armin Alaedini
Journal:  Schizophr Res       Date:  2009-09-11       Impact factor: 4.939

View more
  20 in total

1.  Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study

Authors:  Deanna L. Kelly; Haley K. Demyanovich; Katrina M. Rodriguez; Daniela Ciháková; Monica V. Talor; Robert P. McMahon; Charles M. Richardson; Gopal Vyas; Heather A. Adams; Sharon M. August; Alessio Fasano; Nicola G. Cascella; Stephanie M. Feldman; Fang Liu; MacKenzie A. Sayer; Megan M. Powell; Heidi J. Wehring; Robert W. Buchanan; James M. Gold; William T. Carpenter; William W. Eaton
Journal:  J Psychiatry Neurosci       Date:  2019-07-01       Impact factor: 6.186

Review 2.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

3.  Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.

Authors:  Kirsten E Schoonover; Stacy L Queern; Suzanne E Lapi; Rosalinda C Roberts
Journal:  World J Biol Psychiatry       Date:  2018-12-20       Impact factor: 4.132

Review 4.  Toxoplasma gondii-A Gastrointestinal Pathogen Associated with Human Brain Diseases.

Authors:  E G Severance; J Xiao; L Jones-Brando; S Sabunciyan; Y Li; M Pletnikov; E Prandovszky; R Yolken
Journal:  Int Rev Neurobiol       Date:  2016-10-04       Impact factor: 3.230

Review 5.  Gastroenterology issues in schizophrenia: why the gut matters.

Authors:  Emily G Severance; Emese Prandovszky; James Castiglione; Robert H Yolken
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

6.  Interactions between knockout of schizophrenia risk factor Dysbindin-1 and copper metabolism in mice.

Authors:  Kirsten E Schoonover; Laura J McMeekin; Charlene B Farmer; Neelu E Varghese; Stacy L Queern; Suzanne E Lapi; Rita M Cowell; Rosalinda C Roberts
Journal:  Brain Res Bull       Date:  2020-08-12       Impact factor: 4.077

Review 7.  Macrophages on the margin: choroid plexus immune responses.

Authors:  Jin Cui; Huixin Xu; Maria K Lehtinen
Journal:  Trends Neurosci       Date:  2021-07-24       Impact factor: 13.837

Review 8.  Methods used for the measurement of blood-brain barrier integrity.

Authors:  Huixin Sun; Huiling Hu; Chuanjie Liu; Nannan Sun; Chaohui Duan
Journal:  Metab Brain Dis       Date:  2021-02-26       Impact factor: 3.584

9.  Disruption of the blood-brain barrier in 22q11.2 deletion syndrome.

Authors:  Alexis M Crockett; Sean K Ryan; Adriana Hernandez Vásquez; Caroline Canning; Nickole Kanyuch; Hania Kebir; Guadalupe Ceja; James Gesualdi; Elaine Zackai; Donna McDonald-McGinn; Angela Viaene; Richa Kapoor; Naïl Benallegue; Raquel Gur; Stewart A Anderson; Jorge I Alvarez
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

Review 10.  Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?

Authors:  Jay P Patel; Benicio N Frey
Journal:  Neural Plast       Date:  2015-05-13       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.